Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
HER2
Pharma
Enhertu stalls as AZ, Daiichi navigate 'harder yards' for ADC
Combined Enhertu sales for AstraZeneca and Daiichi Sankyo reached $893 million in Q2, or 1.6% sequential growth from the first quarter.
Angus Liu
Jul 25, 2024 11:12am
Boehringer Ingelheim preps for 2 upcoming oncology launches
Jun 10, 2024 8:20am
ASCO: Enhertu looks to make history again in HER2-ultralow group
Jun 2, 2024 8:00am
AZ, Daiichi tout Enhertu win in earlier, broader HER2-low cancer
Apr 29, 2024 10:38am
As AZ hits $45B revenue goal, is Enhertu nearing a plateau?
Feb 8, 2024 10:48am
Daiichi keeps dialing up Enhertu forecast, advances 2nd AZ ADC
Jan 31, 2024 3:42pm
